Answers are grounded in this paper and cite their sources.
Background Head and neck squamous cell carcinoma (HNSCC) are mainly diagnosed at advanced tumor stage after the onset of symptoms. Timely detection could improve treatment outcome. In the current OncSaliva study we determine the clinical performance of five tumor-specific DNA methylation markers using non-invasive liquid biopsy specimen.
No takes yet. Share an insight, caveat, or question.
Lausch et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: